Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
October 1, 2008
Utility of a patient survey in identifying fluctuations in early stage Parkinson's disease
P A Silburn, G D Mellick, B I Vieira, et al.
The Pharmacogenomics Journal
|
April 5, 2017
Sulfotransferase 1A3/4 copy number variation is associated with neurodegenerative disease
N J Butcher, M K Horne, G D Mellick, et al.
The Journal of Laboratory and Clinical Medicine
|
December 16, 1998
Focused antithrombotic therapy: novel anti-platelet salicylates with reduced ulcerogenic potential and higher first-pass detoxification than aspirin in rats
D Y Hung, G D Mellick, P P Masci, et al.
European Neurology
|
August 31, 2000
The serotonin transporter gene and Parkinson's disease
S J McCann, M E McManus, A G Johnson, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
January 17, 2002
Lack of association between CYP1A1 polymorphism and Parkinson's disease in a Chinese population
D K Y Chan, G D Mellick, D D Buchanan, et al.
Parkinsonism & Related Disorders
|
March 15, 2001
The parkin gene S/N167 polymorphism in Australian Parkinson's disease patients and controls
G D. Mellick, D D. Buchanan, N Hattori, et al.
European Neurology
|
February 19, 1999
The ACE deletion polymorphism is not associated with Parkinson's disease
G D Mellick, D D Buchanan, S J McCann, et al.
Clinical Genetics
|
December 4, 2012
New evidence for, and challenges in, linking small CGG repeat expansion FMR1 alleles with Parkinson's disease
D Z Loesch, F Tassone, J Lo, et al.
Journal of Neurology
|
March 4, 2000
The monoamine oxidase B gene GT repeat polymorphism and Parkinson's disease in a Chinese population
G D Mellick, D D Buchanan, P A Silburn, et al.
Journal of Gastroenterology and Hepatology
|
January 14, 2000
No evidence of increased risk of colorectal cancer in individuals heterozygous for the Cys282Tyr haemochromatosis mutation
G A Macdonald, J Tarish, V J Whitehall, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
October 1, 2008
Utility of a patient survey in identifying fluctuations in early stage Parkinson's disease
P A Silburn, G D Mellick, B I Vieira, et al.
The Pharmacogenomics Journal
|
April 5, 2017
Sulfotransferase 1A3/4 copy number variation is associated with neurodegenerative disease
N J Butcher, M K Horne, G D Mellick, et al.
The Journal of Laboratory and Clinical Medicine
|
December 16, 1998
Focused antithrombotic therapy: novel anti-platelet salicylates with reduced ulcerogenic potential and higher first-pass detoxification than aspirin in rats
D Y Hung, G D Mellick, P P Masci, et al.
European Neurology
|
August 31, 2000
The serotonin transporter gene and Parkinson's disease
S J McCann, M E McManus, A G Johnson, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
January 17, 2002
Lack of association between CYP1A1 polymorphism and Parkinson's disease in a Chinese population
D K Y Chan, G D Mellick, D D Buchanan, et al.
Parkinsonism & Related Disorders
|
March 15, 2001
The parkin gene S/N167 polymorphism in Australian Parkinson's disease patients and controls
G D. Mellick, D D. Buchanan, N Hattori, et al.
European Neurology
|
February 19, 1999
The ACE deletion polymorphism is not associated with Parkinson's disease
G D Mellick, D D Buchanan, S J McCann, et al.
Clinical Genetics
|
December 4, 2012
New evidence for, and challenges in, linking small CGG repeat expansion FMR1 alleles with Parkinson's disease
D Z Loesch, F Tassone, J Lo, et al.
Journal of Neurology
|
March 4, 2000
The monoamine oxidase B gene GT repeat polymorphism and Parkinson's disease in a Chinese population
G D Mellick, D D Buchanan, P A Silburn, et al.
Journal of Gastroenterology and Hepatology
|
January 14, 2000
No evidence of increased risk of colorectal cancer in individuals heterozygous for the Cys282Tyr haemochromatosis mutation
G A Macdonald, J Tarish, V J Whitehall, et al.
Page
of 4